AU Pharma have been in the business of in-licensing products for many years and are well experiences in the areas of Bioequivalence studies, Bio waiver strategies and Dossier compilation for submission to the Australian Therapeutic Goods Administration (TGA).
AU Pharma is also well connected to assist companies dispose of products through out-licensing strategies and agreements that will maximize the benefit to the disposing party.